TB-500 vs BPC-157: Pairing, Differences, Protocols
Two of the most studied body-protection peptides. They are often paired in research because their mechanisms complement rather than overlap.
Mechanisms
BPC-157 — gastric-juice-derived, supports angiogenesis and gut barrier function.
TB-500 — a synthetic fragment of thymosin beta-4, supports actin sequestration and cell migration in injury sites.
Common research protocols
| Peptide | Typical dose | Frequency |
|---|---|---|
| BPC-157 | 250–500 mcg | Daily |
| TB-500 | 2–2.5 mg | 2× weekly |
Why researchers pair them
Different mechanisms acting on different stages of tissue repair — angiogenesis + cell migration. The pair is the most-studied combination in connective-tissue research literature.
Frequently asked questions
Do they interfere with each other?
No published evidence of pharmacological interference.
Same syringe?
No — reconstitute and dose each separately for clean records.
This guide is provided for informational purposes by Next Day Pharma. All peptides supplied are FOR RECONSTITUTION. Always consult a qualified healthcare professional before use.